Use of proteomic patterns in serum to identify ovarian cancer
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
Background New technologies for the detection of early-stage ovarian cancer are urgently needed. Pathological changes within an organ might be reflected in proteomic patterns in serum. We developed a bioinformatics tool and used it to identify proteomic patterns in serum that distinguish neoplastic from non-neoplastic disease within the ovary.Methods Proteomic spectra were generated by mass spectroscopy (surface-enhanced laser desorption and ionisation). A preliminary "training" set of spectra derived from analysis of serum from 50 unaffected women and 50 patients with ovarian cancer were analysed by an iterative searching algorithm that identified a proteomic pattern that completely discriminated cancer from non-cancer. The discovered pattern was then used to classify an independent set of 116 masked serum samples: 50 from women with ovarian cancer, and 66 from unaffected women or those with non-malignant disorders.Findings The algorithm identified a cluster pattern that, in the training set, completely segregated cancer from non-cancer. The discriminatory pattern correctly identified all 50 ovarian cancer cases in the masked set, including all 18 stage I cases. Of the 66 cases of non-malignant disease, 63 were recognised as not cancer. This result yielded a sensitivity of 100% (95% CI 93--100), specificity of 95% (87--99), and positive predictive value of 94% (84--99).Interpretation These findings justify a prospective population-based assessment of proteomic pattern technology as a screening tool for all stages of ovarian cancer in high-risk and general populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A range of clinical samples including serum, urine, or biopsy tissue, have been studied using top-down proteomics to identify protein profiles characteristic of a certain disease generating a more reliable biomarker [155–157].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [156]
Citations
Cites
Holland, J. H. (1992) · The MIT Press eBooks · doi:10.7551/mitpress/1090.001.0001 · Cited by 47,002
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-organized formation of topologically correct feature maps
Kohonen, T. (1982) · Biological Cybernetics · doi:10.1007/bf00337288 · Cited by 9,529
Kohonen, T. (1990) · Proceedings of the IEEE · doi:10.1109/5.58325 · Cited by 8,414
Some Methods for Strengthening the Common χ 2 Tests
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001616 · Cited by 3,718
Pattern Recognition Principles
(2009) · Classification Methods for Remotely Sensed Data, Second Edition · doi:10.1201/9781420090741.ch2 · Cited by 3,173
Self-organized formation of topographically correct feature maps
Kohonen, T. (1982) · Biological Cybernetics · Cited by 2,995
Nonparametric Statistical Methods.
Knott, M., Hollander, M., & Wolfe, D. A. (1974) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344557 · Cited by 2,662
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Tests for Linear Trends in Proportions and Frequencies
Armitage, P. (1955) · Biometrics · doi:10.2307/3001775 · Cited by 2,071
Kohonen, T. (1998) · Neurocomputing · doi:10.1016/s0925-2312(98)00030-7 · Cited by 1,968
Nonparametric Statistical Methods
Ramsey, P. H. (2000) · Technometrics · doi:10.1080/00401706.2000.10486020 · Cited by 1,673
Pattern Recognition Principles
Kavzoglu, T., Tso, B., & Mather, P. M. (2024) · Classification Methods for Remotely Sensed Data · doi:10.1201/9781003439172-2 · Cited by 1,053
Principles and Practice of Gynecologic Oncology
Hoskins, W. J., Pérez, C. A., & Young, R. C. (1992) · Cited by 945
Nonparametric Statistical Methods, 2nd, Ed.
Borror, C. M. (2001) · Journal of Quality Technology · doi:10.1080/00224065.2001.11980073 · Cited by 874
Principles and Practice of Gynecologic Oncology
Moore, W. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00022 · Cited by 838
Screening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
Proteome Research: New Frontiers in Functional Genomics
(1997) · Principles and Practice · doi:10.1007/978-3-662-03493-4 · Cited by 480
Cohen, L. S., Escobar, P. F., Scharm, C., Glimco, B., & Fishman, D. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6253 · Cited by 203
Self-citationComposition of the peptide fraction in human blood plasma: database of circulating human peptides
Richter, R., Schulz-Knappe, P., Schrader, M., Ständker, L., Jürgens, M., Tammen, H., & Forssmann, W.-G. (1999) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00012-2 · Cited by 193
Recent developments in ovarian cancer screening
Menon, U., & Jacobs, I. J. (2000) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200002000-00007 · Cited by 121
Two-Dimensional Electrophoresis: The State of the Art and Future Directions
Herbert, B. R., Sanchez, J., & Bini, L. (1997) · Principles and practice · doi:10.1007/978-3-662-03493-4_2 · Cited by 75
Neural Network Assessment of Perioperative Cardiac Risk in Vascular Surgery Patients
Lapuerta, P., L'Italien, G. J., Paul, S. D., Hendel, R. C., Leppo, J. A., Fleisher, L. A., Cohen, M. C., Eagle, K. A., & Giugliano, R. P. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800114 · Cited by 49
Pharmacogenomics of cytochrome P450 and other enzymes involved in biotransformation of xenobiotics
Guengerich, F. P. (2000) · Drug Development Research · doi:10.1002/(sici)1098-2299(200001)49:1<34::aid-ddr6>3.0.co;2-w · Cited by 30
Self-citationMyocardial SPET: artificial neural networks describe extent and severity of perfusion defects
Lindahl, Palmer, & Edenbrandt (1999) · Clinical Physiology · doi:10.1046/j.1365-2281.1999.00203.x · Cited by 25
Cited by
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
A review of feature selection techniques in bioinformatics
Saeys, Y., Inza, I., & Larrañaga, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm344 · Cited by 5,244
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Sparsity and Smoothness Via the Fused Lasso
Tibshirani, R., Saunders, M., Rosset, S., Zhu, J., & Knight, K. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00490.x · Cited by 2,724
Metadata
- Authors
- Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., & Liotta, L. A.
- Affiliations
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- Northwestern University (US)
- Corresponding author
- Petricoin, Emanuel F
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 359
- Issue
- 9306
- Pages
- 572-577
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2134389439
- Cited by
- 3,236
- References
- 27
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 37 · 2023: 38 · 2022: 36 · 2021: 59 · 2020: 51 · 2019: 67 · 2018: 53 · 2017: 49 · 2016: 50 · 2015: 76 · 2014: 83 · 2013: 92 · 2012: 128
- FWCI
- 338.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- Australian Government
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- ovarian cancer, cancer screening, early-stage cancer detection, mass spectrometry, algorithmic classification, vulnerable populations
- MeSH terms
- Female, Humans, Mass Screening, Ovarian Neoplasms, Predictive Value of Tests, CA-125 Antigen, Proteome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.